Xenpozyme (olipudase alfa or olipudase alfa-rpcp) is the only medication approved for use in adults and children with a rare, genetic condition called acid sphingomyelinase deficiency (ASMD). It's infused into the veins every 2 weeks by a healthcare provider. Because Xenpozyme (olipudase alfa) can put you at risk for serious allergic and infusion-related reactions, your provider will give you pretreatment medications before each infusion.
Xenpozyme (olipudase alfa) is an enzyme replacement therapy. If you have ASMD, your body can't make enough of an enzyme (protein) called acid sphingomyelinase (ASM). ASM is required to break down a specific type of fat in your cells called sphingomyelins. Without ASM, there's a build-up of sphingomyelins in your liver, spleen, lung, and brain. This can cause damage your organs.
Xenpozyme (olipudase alfa) serves as a replacement for ASM, which allows your body to break down the fat (sphingomyelins) in your cells.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Adults
Children
Adults
Children
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
More tips for people administering Xenpozyme (olipudase alfa) at home:
ASMD is a rare, genetic condition. People with ASMD are missing a specific enzyme that helps break down a type of fat. As a result, they experience a build-up of fat and that leads to organ damage. Signs and symptoms of ASMD will depend on which organs are affected, but the most common are an enlarged stomach, cough, difficulty breathing, easily bruising or bleeding, stomach pain, and diarrhea.
ASMD is a genetic problem and Xenpozyme (olipudase alfa) only helps ease certain symptoms. Your provider will likely have you continue Xenpozyme (olipudase alfa) treatment as long as it's helping your condition and you're able to tolerate the side effects. Talk with your provider if you're not sure how long you need to receive Xenpozyme (olipudase alfa) treatment.
Let your provider know if you're thinking about receiving Xenpozyme (olipudase alfa) treatment at home. You'll receive the starting doses of Xenpozyme (olipudase alfa) at a clinic or infusion center. During this time, your provider will slowly raise your dose over the course of a few months. Once you've reached the maintenance dose, your provider will monitor you to see if you can tolerate this dose without any serious side effects. If so, your provider might approve of Xenpozyme (olipudase alfa) home infusions if they think it's safe for you. If approved, you'll need to prep your home for home infusions. A trained nurse will come to your home each time to give you Xenpozyme (olipudase alfa) and stay with you throughout the whole infusion.
Yes. Your provider will order blood tests to check you liver health a month before you start Xenpozyme (olipudase alfa). You'll also need to get blood tests to check your liver before each infusion, at least during the time when your provider is slowly raising your dose. This is because Xenpozyme (olipudase alfa) can cause liver damage and you might not experience any noticeable symptoms. If you're female, your provider will also give you a pregnancy test before you start Xenpozyme (olipudase alfa) to make sure you're not pregnant. This is because Xenpozyme (olipudase alfa) might cause serious harm to unborn babies if taken during pregnancy. If you're not sure whether your tests are scheduled, please check in with your provider.
Your provider might have prescribed you pre-medications (e.g., corticosteroid, antihistamine, or fever medication) to take before your infusion to help lower your risk for severe allergic and infusion reactions. Make sure to take your medications about 30 minutes before your Xenpozyme (olipudase alfa) dose.
Xenpozyme (olipudase alfa) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Xenpozyme (olipudase alfa) can cause serious, sometimes life-threatening, allergic reactions. These reactions can happen during any Xenpozyme (olipudase alfa) infusion, even if you've safely received infusions before. Because of this, your provider might give you pretreatment medications, such as diphenhydramine (Benadryl), acetaminophen (Tylenol), and corticosteroids, to lower your risk for these reactions. You'll also need to get your Xenpozyme (olipudase alfa) at a facility that has the equipment to give you medical care in case of an allergic reaction. If you experience a reaction, your provider might stop or pause the infusion, slow the infusion, or lower the dose of your medication. Get medical help right away if you experience symptoms of a serious allergic reaction, such as trouble breathing, tightness in your throat, hives and itching, and a fast heartbeat.
Xenpozyme (olipudase alfa) can also cause infusion-related reactions. Most people might experience these reactions during the first few months of treatment, when their provider is slowly raising their dose. These reactions typically happen within 2 days of the infusion. The pretreatment medications can lower your risk for these reactions. Let your provider know if you experience symptoms of infusion-related reactions, such as fever, headache, nausea, vomiting, and rash.
Xenpozyme (olipudase alfa) can cause liver damage. This usually occurs within 2 days of the infusion. Typically, you won't notice any symptoms. But your provider can tell whether or not you're having liver problems based on blood work. Because of this risk, your healthcare provider will order labs to check your liver health a month before you start Xenpozyme (olipudase alfa) treatment. You'll likely need to get labs before each infusion to make sure your liver is working properly. If you have liver damage, your provider might need to pause Xenpozyme (olipudase alfa) infusions to give your liver a chance to recover and to prevent further damage. Get medical attention right away if you notice swelling of your stomach, stomach pain, yellowing of your skin or the whites of your eyes, stool changes (black, tarry, or bloody stools), nausea, vomiting, confusion, or dark or brown urine.
Xenpozyme (olipudase alfa) isn't recommended during pregnancy because of the potential harm it can cause to unborn babies (e.g., brain and other developmental problems). Your provider will ask you take a pregnancy test before you start Xenpozyme (olipudase alfa). Females who are able to get pregnant should use birth control during treatment and for at least 2 weeks after treatment with Xenpozyme (olipudase alfa). If you're pregnant or thinking of becoming pregnant, talk to your provider about the risks and benefits of using Xenpozyme (olipudase alfa) during pregnancy.
Your provider will determine your (or your child's) dose of Xenpozyme (olipudase alfa) based on body weight.
Xenpozyme (olipudase alfa) is given as an infusion into the veins (IV) every 2 weeks by a healthcare provider.
The typical starting dose is 0.03 mg/kg (for children up to 17 years) or 0.1 mg/kg (for adults). Your provider will raise the dose slowly over the course of a few months until you (or your child) reach the recommended maintenance dose of 3 mg/kg IV every 2 weeks.